FDA warns of ‘rare but severe itching’ after using popular allergy medications
- The FDA issued a warning on May 16, 2025, about rare but severe itching after stopping popular allergy medications Zyrtec and Xyzal.
- This warning followed reports from 209 cases of intense pruritus appearing days after ceasing daily use of these medicines for several weeks or longer.
- Many patients experienced itching severe enough to disrupt daily life, requiring medical intervention, including hospitalization and disability.
- The FDA advised individuals to consult their healthcare providers if they have any doubts or worries regarding the potential dangers of using these medications and has requested that pruritus warnings be included on the labels of Zyrtec and Xyzal.
- Although the reaction is very rare given widespread use, the FDA cannot determine how likely itching occurs after stopping these antihistamines, so patient caution is advised.
Insights by Ground AI
Does this summary seem wrong?
14 Articles
14 Articles
All
Left
2
Center
9
Right
1
Hay Fever: Why Symptoms Are So Bad This Year And What To Do About It
Hay fever can be annoying at the best of times. But this year, many people are reporting their usual symptoms are worse than ever before with their normal go-to remedies doing little to provide relief.
·New Delhi, India
Read Full ArticleFDA warns of 'rare but severe itching' after using popular allergy medications
(NEXSTAR) – Hundreds of people who stopped using allergy medications like Zyrtec and Xyzal noticed an uncomfortable new side effect, the U.S. Food and Drug Administration said in a warning issued this month. In "rare but severe" cases, and for unknown reasons, some who quit using the drugs became very itchy and had to seek medical help. "Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that re…
Coverage Details
Total News Sources14
Leaning Left2Leaning Right1Center9Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
L 17%
C 75%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage